Funda Meric-Bernstam

Funda Meric-Bernstam, MD is the Chair of the Department of Investigational Cancer Therapeutics and Medical Director of the Institute for Personalized Cancer Therapy at MD Anderson Cancer Center. She holds the Nellie B. Connally Chair in Breast Cancer. Her research focuses on molecular therapeutics, Phase I/II clinical trials, and genomic-driven precision oncology. She leads efforts in genomic testing frameworks, precision decision-support systems, and public curation platforms like personalizedcancertherapy.org. Her work integrates biomarker development, combination therapies, and clinical trial optimization to enhance cancer treatment efficacy.

Her clinical and translational research emphasizes novel drug mechanisms, biomarker-guided therapy, and overcoming treatment resistance. She has contributed to frameworks for rapid genomic assessment, clinical trial enrollment systems, and precision oncology teams. Her leadership spans academic and clinical domains, including roles in the Department of Breast Surgical Oncology and the Department of Cancer Biology.